delta opioid receptor antagonist (GinkgoPharma Co. Ltd./Shanghai Institutes for Biological Sciences Chinese Academy of Sciences)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namedelta opioid receptor antagonist (GinkgoPharma Co. Ltd./Shanghai Institutes for Biological Sciences Chinese Academy of Sciences)
Drug Alias NameGP-415
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionδ-opioid receptor antagonists
Targetsδ-opioid receptor
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesGinkgopharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGinkgopharma Co LtdShanghai Academy Of Life Sciences, Chinese Academy Of Sciences
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A